Harm reduction in tobacco control: where do we draw the line?

Al‐Hamdani, Mohammed; Manly, Eden

doi:10.1057/s41271-021-00327-5

Cited by 3 publications

(2 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One potential strategy is THR, yet these approaches remain controversial within many tobacco control and prevention agencies [12][13][14], especially given the cooptation of harm reduction by Big Tobacco [15]. THR strategies are defined by the substitution of less toxic forms of NT (e.g., e-cigarettes, snus, nicotine replacement therapies) for extremely toxic combustible products (e.g., cigarettes) [16,17].…”

Section: Introductionmentioning

confidence: 99%

Harm perceptions of vaping nicotine relative to cigarette smoking among sexual and gender minority young adults

Lipperman‐Kreda,

Sanders,

Annechino

et al. 2024

Drug and Alcohol Review

View full text Add to dashboard Cite

IntroductionTo address gaps in existing research, the current study used a mixed‐methods approach to describe, contextualise and understand harm perceptions of vaping nicotine relative to cigarette smoking and associations with nicotine and tobacco (NT) use among young adults who identify their genders and sexualities in ways that classify them as sexual and gender minorities (SGM).MethodsResults are based on cross‐sectional surveys and online qualitative interviews with 98 SGM young adults (18–25 years old) in California's San Francisco Bay Area who currently or formerly used combustible tobacco. We generated a measure assessing participants' relative harm perceptions of e‐cigarette use versus cigarette smoking and identified those who perceived cigarette smoking as more harmful than e‐cigarette use compared to those who perceived it to be equally or less harmful.ResultsWe found that relative harm perceptions of cigarette smoking versus e‐cigarette use are likely related to much uncertainty and confusion about the harms of e‐cigarette use. Moreover, findings illustrate that public health messages regarding the risks of e‐cigarette use may have unintended consequences of increasing cigarette use to replace e‐cigarette use for some SGM young adults, a practice that is incongruent with scientific evidence demonstrating that cigarettes and other combustible tobacco products are riskier than e‐cigarettes and other forms of NT use.Discussion and ConclusionsResults suggest the need for evidence‐based, clear, and direct messaging about the relative harms of cigarettes versus e‐cigarettes to reduce NT‐related inequities in SGM populations.

show abstract

Section: Introductionmentioning

confidence: 99%

Harm perceptions of vaping nicotine relative to cigarette smoking among sexual and gender minority young adults

Lipperman‐Kreda,

Sanders,

Annechino

et al. 2024

Drug and Alcohol Review

View full text Add to dashboard Cite

show abstract

“…Harm reduction and prevention efforts focus on ensuring individuals have access to evidence-based interventions, support services, and treatment options. This includes providing opioid agonist treatment, which involves substituting illicit opioids with prescribed medications such as methadone or buprenorphine [ 9 , 14 , 15 ]. Opioid agonist treatment helps individuals manage their substance use disorder, reduce cravings, and improve their overall well-being [ 12 , 13 , 16 ].…”

Section: Introductionmentioning

confidence: 99%

Analysis and mapping of harm reduction research in the context of injectable drug use: identifying research hotspots, gaps and future directions

Sweileh

2024

Harm Reduct J

View full text Add to dashboard Cite

Background Harm reduction is a crucial approach in addressing the multifaceted challenges of injectable drug use. This paper presents an analysis and mapping of the existing literature on harm reduction research in the context of injectable drug use. By reviewing a comprehensive set of scholarly articles, this study identifies research hotspots, knowledge gaps, and future directions in the field. The findings provide valuable insights for researchers, policymakers, and practitioners to guide future research efforts and inform evidence-based harm reduction interventions. Methods Data for the study was obtained from the Scopus database, using keywords and phrases related to harm reduction and injectable drug use. Validation methods were employed to verify the accuracy and comprehensiveness of the search strategy. Data analysis involved identifying growth patterns, key contributors, mapping frequent terms, identifying research hotspots, and identifying emerging research directions. Results A total of 971 articles were found, with a notable increase from 2015 to 2022. The International Journal of Drug Policy (n = 172, 17.7%) and the Harm Reduction Journal (n = 104, 10.7%) were the most prolific journals, and the United States (n = 558, 57.5%) had the highest number of publications. The Johns Hopkins University (n = 80, 8.5%) was the most prolific institution. Mapping of frequent author keywords revealed the main keywords, including harm reduction, HIV, hepatitis C, and opioid overdose. The highly cited articles cover a broad time span and focus on topics like naloxone distribution, HIV and hepatitis C transmission, while recent articles concentrate on emerging issues such as the impact of the COVID-19 pandemic, fentanyl-related concerns, stigma reduction, and needle and syringe programs. Both sets of articles share a common focus on harm reduction strategies, but recent publications highlight current challenges and developments in the field. Conclusions This study provides insights into research landscape on harm reduction in injectable drug use. Research is concentrated in high-income countries, emphasizing the need for more research in low- and middle-income countries. Recent publications focus on emerging challenges like COVID-19 and fentanyl. Research gaps highlight the need for studies in diverse populations, social determinants, program evaluation, and implementation strategies to enhance harm reduction interventions.

show abstract

Urgent action needed: addressing the regulatory gap in e-cigarette trade and usage

Izquierdo-Condoy,

Ortiz-Prado

2024

J Public Health Pol

View full text Add to dashboard Cite

Tobacco use is associated with serious health problems. Global efforts, such as the World Health Organization’s Framework for Tobacco Control, have reduced tobacco use, but challenges remain. Initially perceived as aids for smoking cessation, e-cigarettes have gained popularity among young people and non-smokers. Government approaches to regulating e-cigarettes range from treating them like tobacco, requiring a prescription for their use to outright bans. Although touted as a valuable alternative, evidence suggests that increased e-cigarette use carries potential direct and indirect health risks, necessitating urgent regulatory measures on a global scale. Lack of defined and uniform regulations poses substantial public health risks, compounded by marketing targeting vulnerable groups. Immediate interventions, public awareness, and research are essential to effectively control the current e-cigarette epidemic.

show abstract

Harm reduction in tobacco control: where do we draw the line?

Cited by 3 publications

References 29 publications

Harm perceptions of vaping nicotine relative to cigarette smoking among sexual and gender minority young adults

Harm perceptions of vaping nicotine relative to cigarette smoking among sexual and gender minority young adults

Analysis and mapping of harm reduction research in the context of injectable drug use: identifying research hotspots, gaps and future directions

Urgent action needed: addressing the regulatory gap in e-cigarette trade and usage

Contact Info

Product

Resources

About